Categories: News

Dr. Wilson DuMornay Now Offering Thyroid Radiofrequency Ablation (RFA) at Broward ENT & Aesthetics

FORT LAUDERDALE, Fla., Feb. 27, 2025 /PRNewswire/ — Patients with benign thyroid nodules can now access a cutting-edge, non-surgical treatment option with Thyroid Radiofrequency Ablation (RFA) at Broward ENT & Aesthetics, led by Dr. Wilson DuMornay.

Thyroid RFA is a minimally invasive, non-surgical procedure that effectively shrinks benign thyroid nodules, reducing symptoms such as difficulty swallowing, discomfort, and cosmetic concerns. Clinical studies have shown that patients can achieve an 80% reduction in nodule volume 12 months after RFA treatment. Unlike traditional thyroid surgery, RFA preserves normal thyroid function, eliminates the need for lifelong hormone replacement therapy, and offers a faster recovery with minimal downtime.

Dr. DuMornay, a leader in advanced ENT procedures, is bringing this innovative, scar-free solution to patients in Fort Lauderdale and surrounding areas. “Thyroid RFA is a game-changer for those looking to avoid surgery while effectively managing thyroid nodules,” says Dr. DuMornay. “I’m excited to offer this safe and proven technology to improve patient outcomes.”

Additionally, insurance coverage is now available for Thyroid RFA, making this treatment more accessible to patients. Coverage varies based on individual insurance plans, and patients are encouraged to check with their provider regarding eligibility.

The in-office procedure is performed under local anesthesia, typically lasting 15–40 minutes, depending on the size of the nodule. Patients remain under observation for an additional 45–90 minutes before discharge. Using STARmed’s advanced RF technology, Dr. DuMornay ensures the highest standard of care with the most clinically proven system. STARmed RF System is the only RF technology featured in over 80% of all thyroid RFA clinical studies, demonstrating its unmatched safety and efficacy in treating benign thyroid nodules.

As more people seek non-surgical thyroid treatments, RFA is becoming a preferred option among physicians and patients.

Schedule a Consultation

For more information or to book an appointment with Dr. Wilson DuMornay, visit Broward ENT & Aesthetics or call (954) 368-3348. The clinic is located at 2307 W Broward Blvd, Suite 201, Fort Lauderdale, FL.

About Broward ENT & Aesthetics

Led by Wilson DuMornay, MD, FACS, Broward ENT & Aesthetics is committed to minimally invasive, patient-centered care. The practice specializes in balloon sinuplasty, allergy testing, sleep apnea treatment, ear tubes, head and neck surgery, and Thyroid RFA. Dr. DuMornay integrates STARmed’s RF technology to deliver cutting-edge solutions, ensuring the best possible outcomes for his patients.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dr-wilson-dumornay-now-offering-thyroid-radiofrequency-ablation-rfa-at-broward-ent–aesthetics-302385593.html

SOURCE Broward ENT & Aesthetics; STARmed America Inc.

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

8 minutes ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

8 minutes ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

8 minutes ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

8 minutes ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

8 minutes ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

8 minutes ago